Lv7382
3968 积分 2024-09-04 加入
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
8天前
已完结
The evolving landscape of obesity pharmacotherapy
13天前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
19天前
已完结
Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-68oo, a poly(ADP- ribose) polymerase inhibitor
1个月前
已完结
A Novel Methionine-Based Signaling Mechanism Regulating the Expression of Thymidylate Synthase
1个月前
已完结
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity
1个月前
已完结
Topoisomerase I inhibitors: Challenges, progress and the road ahead
3个月前
已完结
Topoisomerase I inhibitors: camptothecins and beyond
3个月前
已完结
Synthesis and antitumor activity of a series of lactone-opened camptothecin derivatives
3个月前
已完结
皖公网安备34019202002308
